TruNativ bags $30M Series B from OrbiMed to scale clean-label nutrition across channels
Mumbai-based TruNativ, founded 2019, closed a $30 million Series B led by OrbiMed. Capital will fund expansion across D2C, quick commerce, modern trade and pharmacy, while scaling its B2B2C ingredient arm supplying Indian consumer brands.
TruNativ, a Mumbai-based clean-label nutrition D2C startup, raised $30 million Series B led by OrbiMed. Funds will expand distribution across D2C, quick commerce, modern trade and pharmacy, plus grow its B2B2C ingredient business supplying Indian consumer brands.
Why this matters
Builds on TruNativ's parallel push into Tier I/II offline retail with supplements, signaling a coordinated omnichannel and ingredient-supply expansion backed by fresh institutional capital.
Retail-brand activity steady with 1,541 signals in the last 90 days.